Allogeneic hematopoietic stem cell transplantation in the COVID-19 era

Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) recipients are especially vulnerable to coronavirus disease 19 (COVID-19), because of their profound immunodeficiency. Indeed, the first pandemic wave was marked by a high mortality rate in this population. Factors increasing immunodepre...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Jonathan Bordat, Sébastien Maury, Mathieu Leclerc
التنسيق: مقال
اللغة:English
منشور في: Frontiers Media S.A. 2023-02-01
سلاسل:Frontiers in Immunology
الموضوعات:
الوصول للمادة أونلاين:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1100468/full